Selected research
Industry Research
CCL14 Antibody Industry Research Report 2026
Market perspective
The global CCL14 Antibody market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for CCL14 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for CCL14 Antibody is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for CCL14 Antibody is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of CCL14 Antibody include Thermo Fisher Scientific, Boster Biological Technology, Sino Biological, Inc., MyBiosource, Inc., LifeSpan BioSciences, Inc, Creative Diagnostics, Creative Biolabs, Cepham Life Sciences and Bio-Techne, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global CCL14 Antibody market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
CCL14 Antibody Market by Company
Thermo Fisher Scientific
Boster Biological Technology
Sino Biological, Inc.
MyBiosource, Inc.
LifeSpan BioSciences, Inc
Creative Diagnostics
Creative Biolabs
Cepham Life Sciences
Bio-Techne
Biorbyt
Abbexa
Abcam
CCL14 Antibody Segment by Type
Monoclonal Antibody
Polyclonal Antibody
CCL14 Antibody Segment by Application
Western Blot
Flow Cytometry
ELISA
Immunoprecipitation
Immunofluorescence
Other
CCL14 Antibody Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CCL14 Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of CCL14 Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CCL14 Antibody.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of CCL14 Antibody manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of CCL14 Antibody by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of CCL14 Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Monoclonal Antibody
- Polyclonal Antibody
Applications
- Western Blot
- Flow Cytometry
- ELISA
- Immunoprecipitation
- Immunofluorescence
- Other
Companies covered
- Thermo Fisher Scientific
- Boster Biological Technology
- Sino Biological, Inc.
- MyBiosource, Inc.
- LifeSpan BioSciences, Inc
- Creative Diagnostics
- Creative Biolabs
- Cepham Life Sciences
- Bio-Techne
- Biorbyt
- Abbexa
- Abcam
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global CCL14 Antibody Market Size (2021-2032)
- 2.2.2 Global CCL14 Antibody Sales (2021-2032)
- 2.2.3 Global CCL14 Antibody Market Average Price (2021-2032)
- 2.3 CCL14 Antibody by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Monoclonal Antibody
- 2.3.3 Polyclonal Antibody
- 2.4 CCL14 Antibody by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Western Blot
- 2.4.3 Flow Cytometry
- 2.4.4 ELISA
- 2.4.5 Immunoprecipitation
- 2.4.6 Immunofluorescence
- 2.4.7 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global CCL14 Antibody Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global CCL14 Antibody Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global CCL14 Antibody Revenue of Manufacturers (2021-2026)
- 3.4 Global CCL14 Antibody Average Price by Manufacturers (2021-2026)
- 3.5 Global CCL14 Antibody Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of CCL14 Antibody, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of CCL14 Antibody, Product Type & Application
- 3.8 Global Manufacturers of CCL14 Antibody, Established Date
- 3.9 Global CCL14 Antibody Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Thermo Fisher Scientific
- 4.1.1 Thermo Fisher Scientific Company Information
- 4.1.2 Thermo Fisher Scientific Business Overview
- 4.1.3 Thermo Fisher Scientific CCL14 Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Thermo Fisher Scientific CCL14 Antibody Product Portfolio
- 4.1.5 Thermo Fisher Scientific Recent Developments
- 4.2 Boster Biological Technology
- 4.2.1 Boster Biological Technology Company Information
- 4.2.2 Boster Biological Technology Business Overview
- 4.2.3 Boster Biological Technology CCL14 Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Boster Biological Technology CCL14 Antibody Product Portfolio
- 4.2.5 Boster Biological Technology Recent Developments
- 4.3 Sino Biological, Inc.
- 4.3.1 Sino Biological, Inc. Company Information
- 4.3.2 Sino Biological, Inc. Business Overview
- 4.3.3 Sino Biological, Inc. CCL14 Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sino Biological, Inc. CCL14 Antibody Product Portfolio
- 4.3.5 Sino Biological, Inc. Recent Developments
- 4.4 MyBiosource, Inc.
- 4.4.1 MyBiosource, Inc. Company Information
- 4.4.2 MyBiosource, Inc. Business Overview
- 4.4.3 MyBiosource, Inc. CCL14 Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 MyBiosource, Inc. CCL14 Antibody Product Portfolio
- 4.4.5 MyBiosource, Inc. Recent Developments
- 4.5 LifeSpan BioSciences, Inc
- 4.5.1 LifeSpan BioSciences, Inc Company Information
- 4.5.2 LifeSpan BioSciences, Inc Business Overview
- 4.5.3 LifeSpan BioSciences, Inc CCL14 Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 LifeSpan BioSciences, Inc CCL14 Antibody Product Portfolio
- 4.5.5 LifeSpan BioSciences, Inc Recent Developments
- 4.6 Creative Diagnostics
- 4.6.1 Creative Diagnostics Company Information
- 4.6.2 Creative Diagnostics Business Overview
- 4.6.3 Creative Diagnostics CCL14 Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Creative Diagnostics CCL14 Antibody Product Portfolio
- 4.6.5 Creative Diagnostics Recent Developments
- 4.7 Creative Biolabs
- 4.7.1 Creative Biolabs Company Information
- 4.7.2 Creative Biolabs Business Overview
- 4.7.3 Creative Biolabs CCL14 Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Creative Biolabs CCL14 Antibody Product Portfolio
- 4.7.5 Creative Biolabs Recent Developments
- 4.8 Cepham Life Sciences
- 4.8.1 Cepham Life Sciences Company Information
- 4.8.2 Cepham Life Sciences Business Overview
- 4.8.3 Cepham Life Sciences CCL14 Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Cepham Life Sciences CCL14 Antibody Product Portfolio
- 4.8.5 Cepham Life Sciences Recent Developments
- 4.9 Bio-Techne
- 4.9.1 Bio-Techne Company Information
- 4.9.2 Bio-Techne Business Overview
- 4.9.3 Bio-Techne CCL14 Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Bio-Techne CCL14 Antibody Product Portfolio
- 4.9.5 Bio-Techne Recent Developments
- 4.10 Biorbyt
- 4.10.1 Biorbyt Company Information
- 4.10.2 Biorbyt Business Overview
- 4.10.3 Biorbyt CCL14 Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Biorbyt CCL14 Antibody Product Portfolio
- 4.10.5 Biorbyt Recent Developments
- 4.11 Abbexa
- 4.11.1 Abbexa Company Information
- 4.11.2 Abbexa Business Overview
- 4.11.3 Abbexa CCL14 Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Abbexa CCL14 Antibody Product Portfolio
- 4.11.5 Abbexa Recent Developments
- 4.12 Abcam
- 4.12.1 Abcam Company Information
- 4.12.2 Abcam Business Overview
- 4.12.3 Abcam CCL14 Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Abcam CCL14 Antibody Product Portfolio
- 4.12.5 Abcam Recent Developments
5 Global CCL14 Antibody Market Scenario by Region
- 5.1 Global CCL14 Antibody Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global CCL14 Antibody Sales by Region: 2021-2032
- 5.2.1 Global CCL14 Antibody Sales by Region: 2021-2026
- 5.2.2 Global CCL14 Antibody Sales by Region: 2027-2032
- 5.3 Global CCL14 Antibody Revenue by Region: 2021-2032
- 5.3.1 Global CCL14 Antibody Revenue by Region: 2021-2026
- 5.3.2 Global CCL14 Antibody Revenue by Region: 2027-2032
- 5.4 North America CCL14 Antibody Market Facts & Figures by Country
- 5.4.1 North America CCL14 Antibody Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America CCL14 Antibody Sales by Country (2021-2032)
- 5.4.3 North America CCL14 Antibody Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe CCL14 Antibody Market Facts & Figures by Country
- 5.5.1 Europe CCL14 Antibody Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe CCL14 Antibody Sales by Country (2021-2032)
- 5.5.3 Europe CCL14 Antibody Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific CCL14 Antibody Market Facts & Figures by Country
- 5.6.1 Asia Pacific CCL14 Antibody Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific CCL14 Antibody Sales by Country (2021-2032)
- 5.6.3 Asia Pacific CCL14 Antibody Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America CCL14 Antibody Market Facts & Figures by Country
- 5.7.1 South America CCL14 Antibody Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America CCL14 Antibody Sales by Country (2021-2032)
- 5.7.3 South America CCL14 Antibody Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa CCL14 Antibody Market Facts & Figures by Country
- 5.8.1 Middle East and Africa CCL14 Antibody Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa CCL14 Antibody Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa CCL14 Antibody Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global CCL14 Antibody Sales by Type (2021-2032)
- 6.1.1 Global CCL14 Antibody Sales by Type (2021-2032) & (k units)
- 6.1.2 Global CCL14 Antibody Sales Market Share by Type (2021-2032)
- 6.2 Global CCL14 Antibody Revenue by Type (2021-2032)
- 6.2.1 Global CCL14 Antibody Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global CCL14 Antibody Revenue Market Share by Type (2021-2032)
- 6.3 Global CCL14 Antibody Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global CCL14 Antibody Sales by Application (2021-2032)
- 7.1.1 Global CCL14 Antibody Sales by Application (2021-2032) & (k units)
- 7.1.2 Global CCL14 Antibody Sales Market Share by Application (2021-2032)
- 7.2 Global CCL14 Antibody Revenue by Application (2021-2032)
- 7.2.1 Global CCL14 Antibody Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global CCL14 Antibody Revenue Market Share by Application (2021-2032)
- 7.3 Global CCL14 Antibody Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 CCL14 Antibody Value Chain Analysis
- 8.1.1 CCL14 Antibody Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 CCL14 Antibody Production Mode & Process
- 8.2 CCL14 Antibody Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 CCL14 Antibody Distributors
- 8.2.3 CCL14 Antibody Customers
9 Global CCL14 Antibody Analyzing Market Dynamics
- 9.1 CCL14 Antibody Industry Trends
- 9.2 CCL14 Antibody Industry Drivers
- 9.3 CCL14 Antibody Industry Opportunities and Challenges
- 9.4 CCL14 Antibody Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst